According to Glenmark Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $1.48 B. In 2022 the company made a revenue of $1.47 B a decrease over the years 2021 revenue that were of $1.62 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.48 B | 0.9% |
2022 | $1.47 B | -9.42% |
2021 | $1.62 B | 13.15% |
2020 | $1.43 B | -1.47% |
2019 | $1.45 B | 6.7% |
2018 | $1.36 B | -3.45% |
2017 | $1.41 B | 8.6% |
2016 | $1.30 B | 20.2% |
2015 | $1.08 B | 2.64% |
2014 | $1.05 B | 11.62% |
2013 | $0.94 B | 6.65% |
2012 | $0.88 B |